We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$202M
Cap. Flow
-$355M
Cap. Flow %
-35.04%
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428

Top Buys

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$14.9M
2
CLGX
Corelogic, Inc.
CLGX
+$14.2M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$13.5M
4
GDRX icon
GoodRx Holdings
GDRX
+$13.3M
5
SHC icon
Sotera Health
SHC
+$13.1M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$32.8M
2
CZR icon
Caesars Entertainment
CZR
+$22.3M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$20.7M
4
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
+$15.2M
5
BHP icon
BHP
BHP
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Technology 10.24%
3 Industrials 10.18%
4 Financials 8.13%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVGO icon
151
EVgo
EVGO
$200M
$1.78M 0.18%
+164,995
New +$1.7M
FNF icon
152
Fidelity National Financial
FNF
$13.9B
$1.77M 0.17%
47,095
-48,127
-51% -$1.62M
FBP icon
153
First Bancorp
FBP
$4.4B
$1.77M 0.17%
191,914
-65,435
-25% -$499K
FTAI icon
154
FTAI Aviation
FTAI
$22.2B
$1.75M 0.17%
87,550
+11,749
+15% +$196K
ACN icon
155
PUT
Accenture
ACN
$89.9B
$1.75M 0.17%
+6,700
New +$1.61M
CDMO
156
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.75M 0.17%
+150,000
New +$1.37M
C icon
157
Citigroup
C
$222B
$1.74M 0.17%
28,098
-34,423
-55% -$1.75M
ELDN icon
158
Eledon Pharmaceuticals
ELDN
$276M
$1.72M 0.17%
+111,555
New +$2.13M
CDXS icon
159
Codexis
CDXS
$135M
$1.7M 0.17%
+75,000
New +$1.23M
BPOP icon
160
Popular Inc
BPOP
$11B
$1.68M 0.17%
29,752
-20,435
-41% -$970K
RNR icon
161
RenaissanceRe
RNR
$13.7B
$1.67M 0.16%
10,059
+97
+1% +$16.5K
CB icon
162
PUT
Chubb
CB
$140B
$1.62M 0.16%
+10,500
New +$1.47M
NOACU
163
DELISTED
Natural Order Acquisition Corp. Unit
NOACU
$1.6M 0.16%
+145,694
New +$1.56M
HECCU
164
DELISTED
Hudson Executive Investment Corp. Units
HECCU
$1.59M 0.16%
139,700
+107,527
+334% +$1.13M
MTACU
165
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$1.57M 0.16%
+150,000
New +$1.56M
CME icon
166
CME Group
CME
$92.2B
$1.56M 0.15%
8,750
– –
ATVI
167
PUT
DELISTED
Activision Blizzard
ATVI
$1.56M 0.15%
16,800
+12,600
+300% +$1.02M
EW icon
168
Edwards Lifesciences
EW
$47.6B
$1.55M 0.15%
+17,000
New +$1.41M
CFIVU
169
DELISTED
CF Acquisition Corp. IV Unit
CFIVU
$1.55M 0.15%
+150,000
New +$1.55M
CFACU
170
DELISTED
CF Finance Acquisition Corp. III Unit
CFACU
$1.53M 0.15%
+142,500
New +$1.47M
AMD icon
171
PUT
Advanced Micro Devices
AMD
$851B
$1.52M 0.15%
16,500
-34,700
-68% -$2.99M
NSH.U
172
DELISTED
NavSight Holdings, Inc. Units, each consisting of one share of Class A Common Stock and one-half of
NSH.U
$1.52M 0.15%
+142,642
New +$1.45M
PACB icon
173
Pacific Biosciences
PACB
$422M
$1.51M 0.15%
+57,213
New +$972K
COF icon
174
Capital One
COF
$124B
$1.5M 0.15%
15,194
-11,533
-43% -$981K
PWP icon
175
Perella Weinberg Partners
PWP
$1.14B
$1.48M 0.15%
+129,650
New +$1.35M
5 6
7
8 9

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.

  • Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
  • Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
  • Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
  • Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
  • Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
  • Maven Securities opened 385 new positions and closed 428 in Q4 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.